RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Pharma-Bio Serv Stock

Pharma-Bio Serv P/E 2024

Pharma-Bio Serv P/E

0

Ticker

PBSV

ISIN

US71711N1000

As of Nov 16, 2024, Pharma-Bio Serv's P/E ratio was 0, a 0% change from the 16.5 P/E ratio recorded in the previous year.

The Pharma-Bio Serv P/E history

Pharma-Bio Serv Aktienanalyse

What does Pharma-Bio Serv do?

Pharma-Bio Serv Inc is an international company based in Puerto Rico that was founded in 1993. The company offers a wide range of high-quality services to the pharmaceutical, biotech, and hospital industries and has become a leading service provider in this field. Pharma-Bio Serv ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/E Details

Deciphering Pharma-Bio Serv's P/E Ratio

The Price to Earnings (P/E) Ratio of Pharma-Bio Serv is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.

Year-to-Year Comparison

Assessing Pharma-Bio Serv's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.

Impact on Investments

The P/E ratio of Pharma-Bio Serv is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.

Interpreting P/E Ratio Fluctuations

Fluctuations in Pharma-Bio Serv’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.

Frequently Asked Questions about Pharma-Bio Serv stock

What is the price-to-earnings ratio of Pharma-Bio Serv?

The price-earnings ratio of Pharma-Bio Serv is currently 0.

How has the price-earnings ratio of Pharma-Bio Serv changed compared to last year?

The price-to-earnings ratio of Pharma-Bio Serv has increased by 0% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Pharma-Bio Serv high compared to other companies?

Yes, the price-to-earnings ratio of Pharma-Bio Serv is high compared to other companies.

How does an increase in the price-earnings ratio of Pharma-Bio Serv affect the company?

An increase in the price-earnings ratio of Pharma-Bio Serv would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Pharma-Bio Serv affect the company?

A decrease in the price-earnings ratio of Pharma-Bio Serv would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Pharma-Bio Serv?

Some factors that influence the price-earnings ratio of Pharma-Bio Serv are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Pharma-Bio Serv pay?

Over the past 12 months, Pharma-Bio Serv paid a dividend of 0.15 USD . This corresponds to a dividend yield of about 28.85 %. For the coming 12 months, Pharma-Bio Serv is expected to pay a dividend of 0.15 USD.

What is the dividend yield of Pharma-Bio Serv?

The current dividend yield of Pharma-Bio Serv is 28.85 %.

When does Pharma-Bio Serv pay dividends?

Pharma-Bio Serv pays a quarterly dividend. This is distributed in the months of January, March, April, February.

How secure is the dividend of Pharma-Bio Serv?

Pharma-Bio Serv paid dividends every year for the past 5 years.

What is the dividend of Pharma-Bio Serv?

For the upcoming 12 months, dividends amounting to 0.15 USD are expected. This corresponds to a dividend yield of 28.03 %.

In which sector is Pharma-Bio Serv located?

Pharma-Bio Serv is assigned to the 'Health' sector.

Wann musste ich die Aktien von Pharma-Bio Serv kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Pharma-Bio Serv from 2/15/2024 amounting to 0.075 USD, you needed to have the stock in your portfolio before the ex-date on 1/29/2024.

When did Pharma-Bio Serv pay the last dividend?

The last dividend was paid out on 2/15/2024.

What was the dividend of Pharma-Bio Serv in the year 2023?

In the year 2023, Pharma-Bio Serv distributed 0.075 USD as dividends.

In which currency does Pharma-Bio Serv pay out the dividend?

The dividends of Pharma-Bio Serv are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Pharma-Bio Serv

Our stock analysis for Pharma-Bio Serv Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Pharma-Bio Serv Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.